HSA
ARNA

Hussman Strategic Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Hussman Strategic Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-15,400
Closed -$969K – 320
2020
Q2 		$969K Sell
15,400
-30,350
-66% -$1.67M 0.25% 163
2020
Q1 		$1.92M Hold
45,750
– – 0.52% 60
2019
Q4 		$2.08M Buy
45,750
+20,000
+78% +$945K 0.66% 50
2019
Q3 		$1.18M Buy
+25,750
New +$1.45M 0.33% 113

Other funds holding ARNA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Alkeon Capital Management
Alkeon Capital Management New York $59.5B AUM 51.63% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
MWNA
Marshall Wace North America New York $23.5B AUM 46.46% 1-Year Est. Return

Hussman Strategic Advisors's ARNA Position: Q3 2020 in Review

Hussman Strategic Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q3 2020, closing a stake of 15,400 shares — an estimated $969K sold.

Hussman Strategic Advisors first reported a position in ARNA in Q3 2019 and held it in 4 quarters. The position peaked at $2.08M in Q4 2019. 253 funds tracked by Wall St. Rank hold ARNA as of Q3 2020.

  • Hussman Strategic Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q3 2020 after selling out during the quarter.
  • Hussman Strategic Advisors sold 15,400 Arena Pharmaceuticals Inc shares in Q3 2020, an estimated $969K.
  • Hussman Strategic Advisors first reported a position in Arena Pharmaceuticals Inc in Q3 2019 and held it in 4 quarters.
  • Hussman Strategic Advisors's Arena Pharmaceuticals Inc position peaked at $2.08M in Q4 2019.
  • 253 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q3 2020.

Based on Hussman Strategic Advisors's 13F filing for Q3 2020, filed 2 Nov 2020.